Elbasvir
编号: 010411
Cas号: 1444832-51-2
纯度: 98%
Elbasvir is a HCV NS5A inhibitor, which is currently in phase 2b clinical trials as part of an all-oral, interferon-free regimen for the treatment of HCV infection. The NS5A protein plays a critical role in the replication of HCV and has been the focus of numerous research efforts over the past few years. NS5A inhibitors have shown impressive in vitro potency profiles in HCV replicon assays, making them attractive components for inclusion in all oral combination regimens.
仅供研究使用。 我们不向患者出售。
化学信息
| 名称 | Elbasvir |
|---|---|
| Iupac 化学名称 | dimethyl ((2S,2'S)-((2S,2'S)-2,2'-(5,5'-((S)-6-phenyl-6H-benzo[5,6][1,3]oxazino[3,4-a]indole-3,10-diyl)bis(1H-imidazole-5,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl))dicarbamate |
| 同义词 | MK8742; MK-8742; MK 8742 |
| 英文同义词 | MK8742; MK-8742; MK 8742 |
| 分子式 | C49H55N9O7 |
| 分子量 | 882.02 |
| Smile | O=C(N1[C@H](C2=NC=C(C3=CC=C4C(N5[C@H](C6=CC=CC=C6)OC4=C3)=CC7=C5C=CC(C8=CN=C([C@H]9N(C([C@@H](NC(OC)=O)C(C)C)=O)CCC9)N8)=C7)N2)CCC1)[C@@H](NC(OC)=O)C(C)C |
| InChiKey | BVAZQCUMNICBAQ-PZHYSIFUSA-N |
| InChi | InChI=1S/C49H55N9O7/c1-27(2)41(54-48(61)63-5)45(59)56-20-10-14-37(56)43-50-25-34(52-43)30-17-19-36-32(22-30)23-39-33-18-16-31(24-40(33)65-47(58(36)39)29-12-8-7-9-13-29)35-26-51-44(53-35)38-15-11-21-57(38)46(60)42(28(3)4)55-49(62)64-6/h7-9,12-13,16-19,22-28,37-38,41-42,47H,10-11,14-15,20-21H2,1-6H3,(H,50,52)(H,51,53)(H,54,61)(H,55,62)/t37-,38-,41-,42-,47-/m0/s1 |
| Cas号 | 1444832-51-2 |
| 相关CAS号 |
订购信息
| 包装 | 价格 | 库存 | 纯度 | 备货期 |
|---|---|---|---|---|
| 大货 | 询价 | 询价 | 询价 |
